Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years

Archive ouverte

Durier, Christine | Ninove, Laetitia | Lefebvre, Maeva | Radenne, Anne | Desaint, Corinne | Ropers, Jacques | Bauer, Rebecca | Lebbah, Said | Carette, Diane | Lachâtre, Marie | Lecompte, Anne-Sophie | Deplanque, Dominique | Botelho-Nevers, Elisabeth | Conrad, Anne | Dussol, Bertrand | Maakaroun-Vermesse, Zoha | Melica, Giovanna | Nicolas, Jean-François | Verdon, Renaud | Kiladjian, Jacques | Loubet, Paul | Schmidt-Mutter, Catherine | Dualé, Christian | Ansart, Séverine | Priet, Stéphane | Levier, Axel | Molino, Diana | Vieillard, Louis-Victorien | Parfait, Béatrice | Lelièvre, Jean-Daniel | Tartour, Eric | de Lamballerie, Xavier | Launay, Odile | Mchantaf, Gilbert | Imbert-Marcille, Berthe-Marie | Montagne, Samantha | Ghaleh-Marzban, Bijan | Traverse-Glehen, Alexandra | Vivien, Denis | Cassinat, Bruno | Evrard, Alexandre | Metzger, Catherine | Lessinger, Jean-Marc | Billing, Michel | Berger, Marc | Leroyer, Christophe | Appay, Victor | Batteux, Frédéric | Combadière, Béhazine | Gorochov, Guy | Paul, Stéphane | van Der Werf, Sylvie | Eberhardt, Christiane | Siegrist, Claire-Anne | Cogné, Michel | Pellegrin, Isabelle | Eloit, Marc | Netzer, Emmanuelle | Resch, Martine | Saouzanet, Marine | Meyer, Laurence | Bonneton, Marion | Tardieu, Raphaelle | Le Mestre, Soizic | Jancrey-Laval, Solange | Petrov-Sanchez, Ventzislava | Rosenthal, Eric | Yazdanpanah, Yazdan | Olive, Daniel | Bouakane, Amel | Rieux, Véronique | Madelaine, Claire | Diallo, Alpha | Valour, Florent | Hisbergues, Michael | Bertholon, Frederique | Icard, Vinca | de Sandre-Giovannoli, Annachiara | Dropy, Margot | Bouchama, Fatiha | Thamri, Mehdi | Azimi, Shorheh

Edité par CCSD ; Nature Publishing Group -

International audience. Immune response induced by COVID-19 vaccine booster against delta and omicron variants was assessed in 65 adults (65–84 years old) early aftesr a first booster dose. An increase in SARS-CoV-2 neutralizing antibodies was shown in individuals not previously infected without evidence of an age-related effect, with lower increase in those infected before a single dose of primary vaccination. Of note, humoral response was observed only starting from the 5th day after the boost.

Suggestions

Du même auteur

Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination

Archive ouverte | Gorochov, Guy | CCSD

International audience. IMPORTANCEThere is still considerable controversy in the literature regarding the capacity of intramuscular messenger RNA (mRNA) vaccination to induce a mucosal immune response. OBJECTIVE To ...

Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination

Archive ouverte | Durier, Christine | CCSD

International audience. Objectives: COVID-19 vaccine breakthrough infections were frequently reported during circulation of the Omicron variant. The ANRS|MIE CoviCompareP study investigated these infections in adult...

A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project

Archive ouverte | Molino, Diana | CCSD

International audience. Significance There is growing evidence that preexisting autoantibodies neutralizing type I interferons (IFNs) are strong determinants of life-threatening COVID-19 pneumonia. It is important t...

Chargement des enrichissements...